-
-
Overview
-
First developed during the COVID-19 pandemic in 2021, PLpro inhibitor has proven to inhibit the PLprocystein protease of SARS-CoV-2 virus.
Please contact us at for specific academic pricing.
-
- Properties
-
Overview